OUR PIPELINE

Abilita Bio is leveraging our EMP™ technology to increase the druggability of G Protein-Coupled Receptors (GPCRs), ion channels, and other membrane proteins through structured collaboration and license agreements with top-tier pharmaceutical and biotech companies, and development of our internal discovery programs.